Cardinal Health Acquires Integrated Oncology Network for $1.115B

What You Should Know: 

Cardinal Health (NYSE: CAH) has announced a definitive agreement to acquire Integrated Oncology Network (ION), a physician-led independent community oncology network, for $1.115 billion in cash. 

– The acquisition will integrate ION into Cardinal’s Navista platform and expand its suite of solutions to deliver world-class patient care and experiences while navigating the complexities of the healthcare landscape.

Expanding Support for Independent Oncology Practices

ION comprises over 50 practice sites across 10 states, with over 100 providers deeply connected to their local communities. Their comprehensive care continuum includes medical oncology, radiation oncology, urology, diagnostic testing, and other ancillary services.

Following the acquisition, ION practices will join Navista, Cardinal Health’s oncology practice alliance. Additionally, ION’s practice management and growth services will be integrated into Navista’s advanced services and technology offerings.

ION practices will also benefit from Navista’s cutting-edge analytics capabilities, which leverage AI and deep expertise from Specialty Networks’ PPS Analytics and SoNaR technology solutions to provide actionable clinical and business insights.

A Comprehensive Suite of Solutions

ION’s adaptable business model and services, including revenue cycle management, payor relations, physician recruitment, and practice marketing, perfectly complement Navista’s existing offerings. Together, they expand Cardinal Health’s holistic suite of clinical and practice management solutions tailored for independent community oncology practices.

“Integrated Oncology Network and Cardinal Health share a mission of helping community oncology practices deliver world-class patient care and a world-class patient experience to patients and families close to home,” said Barry Tanner, CEO, Integrated Oncology Network. “This partnership will give community practices the tools and technology they need to enhance and grow that mission and make a positive impact on patient outcomes.”